BackHillstream BioPharma Overview

Hillstream BioPharma Total Liabilities

Latest total liabilities for HILS: $110M.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$114.86M
4538.81% YoYΔ $112.38M vs prior year quarter

Peer average

Loading

Hillstream BioPharma Total Liabilities History

Loading

Hillstream BioPharma vs. peers: Total Liabilities Comparison

Loading

Hillstream BioPharma Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Hillstream BioPharma (HILS) FAQ

As of the most recent data (March 2026), HILS shows a total liabilities of $110M. That compares with $2.5M in the prior-year period — up 4538.8% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, HILS's total liabilities is now $110M (was $2.5M) — a 4538.8% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Hillstream BioPharma is outperforming or lagging.

Tracking HILS's total liabilities over time shows whether Hillstream BioPharma is scaling, shrinking, or reshaping that part of the business. The current reading is $110M That compares with $2.5M in the prior-year period — up 4538.8% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total liabilities page, Stockcircle has Hillstream BioPharma's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total liabilities (currently $110M) with ownership activity and broader fundamentals.